$KNX
Knight-Swift Transportation Holdings Inc.

2023 Q4 Form 10-Q Financial Statement

#000149269123000093 Filed on November 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $1.932B $2.020B
YoY Change 10.8% 6.49%
Cost Of Revenue $701.0M $746.0M
YoY Change 11.21% 4.86%
Gross Profit $1.231B $1.274B
YoY Change 10.57% 7.47%
Gross Profit Margin 63.71% 63.07%
Selling, General & Admin $941.5M $908.0M
YoY Change 36.66% 30.34%
% of Gross Profit 76.49% 71.27%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $194.5M $176.6M
YoY Change 15.59% 6.0%
% of Gross Profit 15.81% 13.86%
Operating Expenses $1.209B $1.183B
YoY Change 32.78% 28.17%
Operating Profit $21.67M $81.06M
YoY Change -89.3% -69.16%
Interest Expense -$34.82M $39.35M
YoY Change 104.64% -392.42%
% of Operating Profit -160.72% 48.55%
Other Income/Expense, Net $6.844M -$22.38M
YoY Change 23.65% -363.65%
Pretax Income -$9.699M $58.68M
YoY Change -105.08% -77.47%
Income Tax $1.294M -$1.220M
% Of Pretax Income -2.08%
Net Earnings -$10.66M $60.19M
YoY Change -107.17% -69.1%
Net Earnings / Revenue -0.55% 2.98%
Basic Earnings Per Share $0.37
Diluted Earnings Per Share -$0.07 $0.37
COMMON SHARES
Basic Shares Outstanding 161.4M shares 161.3M shares
Diluted Shares Outstanding 161.9M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $168.5M $193.0M
YoY Change -14.34% -0.56%
Cash & Equivalents $168.5M $193.4M
Short-Term Investments
Other Short-Term Assets $586.1M $53.68M
YoY Change 48.17% -83.28%
Inventory
Prepaid Expenses $148.7M $132.6M
Receivables $888.6M $971.2M
Other Receivables $65.82M $60.00M
Total Short-Term Assets $1.709B $1.761B
YoY Change 14.42% 19.45%
LONG-TERM ASSETS
Property, Plant & Equipment $5.101B $4.504B
YoY Change 26.66% 17.42%
Goodwill $3.849B $3.844B
YoY Change 9.36% 9.26%
Intangibles $2.059B $2.077B
YoY Change 15.89% 16.55%
Long-Term Investments
YoY Change
Other Assets $152.9M $147.2M
YoY Change 13.4% 8.43%
Total Long-Term Assets $11.16B $11.08B
YoY Change 18.01% 19.48%
TOTAL ASSETS
Total Short-Term Assets $1.709B $1.761B
Total Long-Term Assets $11.16B $11.08B
Total Assets $12.87B $12.84B
YoY Change 17.52% 19.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $355.2M $299.0M
YoY Change 60.82% 30.27%
Accrued Expenses $530.2M $228.5M
YoY Change 82.89% -31.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $459.8M $435.0M
YoY Change 543.33% 467.26%
Total Short-Term Liabilities $1.825B $1.730B
YoY Change 104.17% 89.66%
LONG-TERM LIABILITIES
Long-Term Debt $2.224B $2.244B
YoY Change 21.47% 24.58%
Other Long-Term Liabilities $766.0M $72.14M
YoY Change 110.5% -78.72%
Total Long-Term Liabilities $2.990B $72.14M
YoY Change 36.23% -96.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.825B $1.730B
Total Long-Term Liabilities $2.990B $72.14M
Total Liabilities $5.783B $5.710B
YoY Change 44.34% 44.9%
SHAREHOLDERS EQUITY
Retained Earnings $2.660B $2.694B
YoY Change 4.16% 11.1%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.087B $7.113B
YoY Change
Total Liabilities & Shareholders Equity $12.87B $12.84B
YoY Change 17.52% 19.47%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$10.66M $60.19M
YoY Change -107.17% -69.1%
Depreciation, Depletion And Amortization $194.5M $176.6M
YoY Change 15.59% 6.0%
Cash From Operating Activities $288.2M $151.3M
YoY Change -14.4% -60.1%
INVESTING ACTIVITIES
Capital Expenditures $218.9M $334.8M
YoY Change -28.07% -266.8%
Acquisitions
YoY Change
Other Investing Activities $78.99M -$337.3M
YoY Change 371.05% -827.02%
Cash From Investing Activities -$140.0M -$672.0M
YoY Change -51.31% 335.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -135.4M 49.50M
YoY Change 2353.97% -125.19%
NET CHANGE
Cash From Operating Activities 288.2M 151.3M
Cash From Investing Activities -140.0M -672.0M
Cash From Financing Activities -135.4M 49.50M
Net Change In Cash 12.74M -471.2M
YoY Change -70.77% -1757.81%
FREE CASH FLOW
Cash From Operating Activities $288.2M $151.3M
Capital Expenditures $218.9M $334.8M
Free Cash Flow $69.26M -$183.5M
YoY Change 114.23% -131.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
299941000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
68550000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
59011000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-18206000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-31104000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
286090000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-748829000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
71562000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8260000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
456907000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
341763000 usd
us-gaap Interest Paid Net
InterestPaidNet
84361000 usd
us-gaap Interest Paid Net
InterestPaidNet
29342000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
38455000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
234260000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
19639000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4264000 usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0 usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
2164000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
174107000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1717000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1462000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
0 usd
knx Conversion Of Note Receivable To Equity Investment
ConversionOfNoteReceivableToEquityInvestment
12107000 usd
knx Conversion Of Note Receivable To Equity Investment
ConversionOfNoteReceivableToEquityInvestment
0 usd
knx Right Of Use Asset Forfeited Obtained In Exchange For Operating Lease Liability
RightOfUseAssetForfeitedObtainedInExchangeForOperatingLeaseLiability
41888000 usd
knx Right Of Use Asset Forfeited Obtained In Exchange For Operating Lease Liability
RightOfUseAssetForfeitedObtainedInExchangeForOperatingLeaseLiability
44465000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
70051000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
141374000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
194082000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
261001000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
144960000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
87241000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2721000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1781000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
341763000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
350023000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6955281000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
163000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
977000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1462000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3060000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
19548000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21059000 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.42
us-gaap Dividends
Dividends
68255000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1772000 usd
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
7555000 usd
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
239000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7129801000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6543450000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2375000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
873000 usd
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
299941000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
20504000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25878000 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.36
us-gaap Dividends
Dividends
58912000 usd
us-gaap Profit Loss
ProfitLoss
622522000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1991000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6816613000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7081043000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1462000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
978000 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1277000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4472000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2023Q3 us-gaap Dividends
Dividends
22764000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
59897000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
151000 usd
CY2023Q3 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
5839000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1054000 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
188000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8926000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2022Q3 us-gaap Dividends
Dividends
19471000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
194792000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
243000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6816613000 usd
CY2023Q3 knx Numberof Tractors In Fleet
NumberofTractorsInFleet
20054 vehicle
CY2023Q3 knx Number Of Tractors Driven By Company Drivers
NumberOfTractorsDrivenByCompanyDrivers
17977 vehicle
CY2023Q3 knx Number Of Owner Operator Tractors
NumberOfOwnerOperatorTractors
2077 vehicle
CY2023Q3 knx Number Of Trailers In Fleet
NumberOfTrailersInFleet
85125 vehicle
CY2023Q3 knx Number Of Ltl Tractors
NumberOfLTLTractors
3177 vehicle
CY2023Q3 knx Number Of Ltl Trailers
NumberOfLTLTrailers
8445 vehicle
CY2023Q3 knx Number Of Intermodal Tractors
NumberOfIntermodalTractors
647 vehicle
CY2023Q3 knx Number Of Intermodal Containers
NumberOfIntermodalContainers
12780 vehicle
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
CY2023Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
264300000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1500000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.021
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.252
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.191
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.249
CY2023Q3 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
14600000 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10400000 usd
CY2023Q3 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
200000 usd
CY2023Q3 us-gaap Open Tax Year
OpenTaxYear
2017
CY2023Q3 us-gaap Secured Debt
SecuredDebt
296884000 usd
CY2022Q4 us-gaap Secured Debt
SecuredDebt
0 usd
CY2023Q3 us-gaap Unsecured Debt
UnsecuredDebt
1582152000 usd
CY2022Q4 us-gaap Unsecured Debt
UnsecuredDebt
1037462000 usd
CY2023Q3 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
320441000 usd
CY2022Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
12794000 usd
CY2023Q3 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
1261711000 usd
CY2022Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
1024668000 usd
CY2023Q3 us-gaap Unsecured Debt
UnsecuredDebt
1582152000 usd
CY2022Q4 us-gaap Unsecured Debt
UnsecuredDebt
1037462000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
1882152000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1080462000 usd
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
173100000 usd
CY2023Q3 us-gaap Debt Instrument Collateral Amount
DebtInstrumentCollateralAmount
256700000 usd
CY2023Q3 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.0558
CY2023Q3 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0486
CY2022Q3 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0433
us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0479
us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0313
CY2023Q3 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.0600
CY2022Q3 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.0600
us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.0600
us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.0600
CY2023Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
9200000 usd
CY2022Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0 shares
CY2022Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
0 usd
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
6001000 shares
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
299941000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
161332000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
160665000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
161124000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
162785000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
556000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
907000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
658000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
935000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
161888000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
161572000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
161782000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
163720000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
57000 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
132000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
141000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
321000 shares
CY2023Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
97878000 usd
CY2023Q3 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
97878000 usd
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
103517000 usd
CY2022Q4 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
103517000 usd
CY2023Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
0 usd
CY2023Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
0 usd
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
1668000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
1668000 usd
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
0 usd
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
0 usd
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
11341000 usd
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
11341000 usd
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
40859000 usd
CY2023Q3 us-gaap Revenues
Revenues
2019936000 usd
CY2022Q3 us-gaap Revenues
Revenues
1896839000 usd
us-gaap Revenues
Revenues
5209847000 usd
us-gaap Revenues
Revenues
5684959000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
81056000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
265441000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
319873000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
889305000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
176613000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
150363000 usd
us-gaap Depreciation
Depreciation
488960000 usd
us-gaap Depreciation
Depreciation
442889000 usd
knx Percentages Of Foreign Operations Consolidated Revenue
PercentagesOfForeignOperationsConsolidatedRevenue
0.050
CY2022Q3 knx Percentages Of Foreign Operations Consolidated Revenue
PercentagesOfForeignOperationsConsolidatedRevenue
0.050
knx Percentages Of Foreign Operations Consolidated Revenue
PercentagesOfForeignOperationsConsolidatedRevenue
0.050
CY2023Q3 knx Percentages Of Foreign Operations Consolidated Revenue
PercentagesOfForeignOperationsConsolidatedRevenue
0.050
CY2022Q4 knx Longlivedassetsofforeignoperations
Longlivedassetsofforeignoperations
0.050
CY2023Q3 knx Longlivedassetsofforeignoperations
Longlivedassetsofforeignoperations
0.050

Files In Submission

Name View Source Status
0001492691-23-000093-index-headers.html Edgar Link pending
0001492691-23-000093-index.html Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
0001492691-23-000093.txt Edgar Link pending
0001492691-23-000093-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
knx-20230930.htm Edgar Link pending
knx-20230930.xsd Edgar Link pending
knx-20230930_g1.jpg Edgar Link pending
knx-ex311x09302023.htm Edgar Link pending
knx-ex312x09302023.htm Edgar Link pending
knx-ex321x09302023.htm Edgar Link pending
knx-ex322x09302023.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
knx-20230930_lab.xml Edgar Link unprocessable
knx-20230930_pre.xml Edgar Link unprocessable
knx-20230930_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
knx-20230930_def.xml Edgar Link unprocessable
knx-20230930_cal.xml Edgar Link unprocessable